SCHEMBL847872

SCHEMBL847872

Cc1nc2c(F)cccc2cc1NC(=O)c1ccc(N2CC3CCC(CC3)C2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 6/20 0.44
TNKS2 Q9H2K2 3/20 0.44
ALDH1A1 P00352 3/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
HDAC3 O15379 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CRACR2A Q9BSW2 1/20 0.38
F10 P00742 1/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
FLT3 P36888 2/20 0.37
CHRNA7 P36544 1/20 0.37
CHRNA10 Q9GZZ6 1/20 0.37
CHRNA9 Q9UGM1 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846022 0.81 TRPV1 (0.43) TNKSTNKS2ALDH1A1NPC1RAB9A
SCHEMBL22410629 0.74 MAPT (0.39) ALDH1A1NPC1RAB9AMAPTLMNA
SCHEMBL845787 0.74 TNKS (0.43) TNKSTNKS2ALDH1A1NPC1RAB9A
SCHEMBL846354 0.73 TRPV1 (0.44) TNKSTNKS2NPC1RAB9AMAPT
SCHEMBL2719453 0.73 SMN1; SMN2 (0.44) ALDH1A1NPC1RAB9AMAPTLMNA
SCHEMBL845882 0.71 TRPV1 (0.43) ALDH1A1NPC1RAB9ACHRNB4CHRNA3
SCHEMBL847871 0.71 MCHR1 (0.42) TNKSTNKS2ALDH1A1NPC1RAB9A
SCHEMBL845899 0.66 TRPV1 (0.47) ALDH1A1NPC1RAB9ACHRNB4CHRNA3
SCHEMBL846941 0.66 RAB9A (0.59) ALDH1A1NPC1RAB9AMAPTLMNA
SCHEMBL20819772 0.66 PDK1 (0.36) ALDH1A1NPC1RAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP claimed